Riskpilot← Back to searchSign inGet full accessBIOSALE DANMARK ApS
APSActiveCVR 34048665Skebjergvej 33Wholesale of chemical products · NACE 4685Est. 20111 employees
Revenue 2024
DKK 202K
-24% vs 2023
EBITDA margin
15.3%
+689% vs 2023
Equity ratio
53.4%
Financial strength
Net profit 2024
DKK 28K
+706% vs 2023
| Revenue | DKK 202K | -24% |
| EBITDA | DKK 31K | +689% |
| Net profit | DKK 28K | +706% |
| Total assets | DKK 567K | -23% |
| Equity | DKK 303K | +10% |
| Employees | 1 | — |
Legal name
BIOSALE DANMARK ApS
CVR number
34048665
Legal form
Anpartsselskab
NACE code
4685 · Wholesale of chemical products
Founded
7. november 2011
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at drive handelsvirksomhed foruden al virksomhed, som efter bestyrelsens skøn er beslægtet hermed.
Address
Skebjergvej 33
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 921 | 824 | 677 | 806 | 637 | 644 | 620 | 455 | 383 | 340 | 410 | 264 | 202 |
| Staff expenses | -719 | -690 | -672 | -668 | -650 | -622 | -593 | -431 | -393 | -316 | -319 | -260 | -171 |
| EBITDA | 144 | 134 | 5 | 139 | -12 | 22 | 27 | 24 | -10 | 24 | 91 | 4 | 31 |
| Depreciation & amort. | 28 | -44 | -117 | -9 | -0 | -0 | -5 | -19 | -33 | -0 | -12 | -35 | -35 |
| EBIT | 116 | 90 | -112 | 129 | -12 | 22 | 22 | 4 | -43 | 24 | 79 | -31 | -4 |
| Net financials | 1 | 0 | -1 | -3 | -1 | 83 | -6 | -3 | -1 | -5 | -32 | 38 | 42 |
| Profit before tax | 116 | 90 | -64 | 127 | -14 | 105 | 15 | 1 | -44 | 19 | 47 | 7 | 38 |
| Tax | 35 | 25 | 25 | 31 | -1 | 6 | 4 | 3 | -6 | 9 | 15 | 3 | 10 |
| Net profit | 82 | 65 | -89 | 96 | -13 | 99 | 11 | -2 | -38 | 10 | 32 | 3 | 28 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 560 | 623 | 731 | 684 | 676 | 535 | 589 | 530 | 521 | 489 | 847 | 737 | 567 |
| Equity | 250 | 314 | 226 | 322 | 309 | 257 | 268 | 267 | 229 | 239 | 271 | 275 | 303 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 10 | 25 | 26 | 129 | 95 | 52 |
| Short-term debt | 307 | 309 | 505 | 362 | 367 | 277 | 317 | 250 | 267 | 224 | 440 | 360 | 205 |
| Total debt | 307 | 309 | 505 | 362 | 367 | 277 | 317 | 260 | 293 | 250 | 569 | 455 | 258 |
EBITDA margin
15.3%
This company
15.8%
Market median
+3% vs market
20122024
Equity ratio
53.4%
This company
38.2%
Market median
+40% vs market
20122024
Return on equity
9.2%
This company
18.4%
Market median
-50% vs market
20122024
Net profit margin
13.8%
This company
8.1%
Market median
+70% vs market
20122024
Asset turnover
0.36×
This company
1.12×
Market median
-68% vs market
20122024
Debt / equity
0.87×
This company
0.62×
Market median
+40% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SV Management | Management | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Chairman | 2011 | — | — | |
| Chairman | 2013 | — | — | |
| Chairman | 2011 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOSALE DANMARK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanne Vestergaard Frederiksen | Management | 0 companies |
| Torben Rughave | Deputy Chairman | 0 companies |
| Margrethe Marie Vestergård Nielsen | Chairman | 0 companies |
| Darling Nielsen | Chairman | 0 companies |